Original Research

Published on 20 Mar 2024

Preoperative systemic immune-inflammation index-based nomogram for lung carcinoma following microwave ablation -a real world single center study

in Thoracic Oncology

Jing Wang
Song-ping Cui
Qing Zhao
Ya Gao
Ying Ji
Yi Liu
Jin-bai Miao
Yi-li Fu
Bin Hu

Frontiers in Oncology

doi 10.3389/fonc.2024.1305262

1,024 views
4 citations

Original Research

Published on 20 Mar 2024

Radiomics model based on intratumoral and peritumoral features for predicting major pathological response in non-small cell lung cancer receiving neoadjuvant immunochemotherapy

in Thoracic Oncology

Dingpin Huang
Chen Lin
Yangyang Jiang
Enhui Xin
Fangyi Xu
Yi Gan
Rui Xu
Fang Wang
Haiping Zhang
Kaihua Lou

Frontiers in Oncology

doi 10.3389/fonc.2024.1348678

1,693 views
1 citation

Original Research

Published on 19 Mar 2024

Plasma metabolomics reveals risk factors for lung adenocarcinoma

in Thoracic Oncology

Mengjie Yu
Wei Wen
Yue Wang
Xia Shan
Xin Yi
Wei Zhu
Jiye Aa
Guangji Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1277206

1,290 views
1 citation

Original Research

Published on 19 Mar 2024

Anti-angiogenic therapy or immunotherapy? A real-world study of patients with advanced non-small cell lung cancer with EGFR/HER2 exon 20 insertion mutations

in Thoracic Oncology

Jiaqi Li
Mengqing Xie
Ruiying Zhao
Huiping Qiang
Qing Chang
Jialin Qian
Haijiao Lu
Yinchen Shen
Yuchen Han
Chunxia Su

Frontiers in Oncology

doi 10.3389/fonc.2024.1357231

1,758 views
2 citations

Case Report

Published on 18 Mar 2024

Case report: Complex left-carina resection: three-year single-center experience

in Thoracic Oncology

Simone Tombelli
Domenico Viggiano
Ottavia Salimbene
Marco Trigiani
Luca Voltolini
Alessandro Gonfiotti

Frontiers in Oncology

doi 10.3389/fonc.2024.1367311

769 views

Case Report

Published on 12 Mar 2024

Case report: Bronchoscopic intervention for rare benign airway tumors: a report of 4 cases and literature review

in Thoracic Oncology

Zhifang Cui
Jinhong Wang
Hongwu Wang
Lei Li
Xiaohui Si
Yanbin Zhang
Heng Zou

Frontiers in Oncology

doi 10.3389/fonc.2024.1357982

1,038 views

Original Research

Published on 11 Mar 2024

The application of artificial intelligence for Rapid On-Site Evaluation during flexible bronchoscopy

in Thoracic Oncology

Shuang Yan
Yongfei Li
Lei Pan
Hua Jiang
Li Gong
Faguang Jin

Frontiers in Oncology

doi 10.3389/fonc.2024.1360831

2,473 views
2 citations

Original Research

Published on 11 Mar 2024

Diagnosis of benign and malignant peripheral lung lesions based on a feature model constructed by the random forest algorithm for grayscale and contrast-enhanced ultrasound

in Thoracic Oncology

Hong Wei
Yichun Wang
Jinyao Li
Yanyan Wang
Longdi Lu
Jiawei Sun
Xiaolei Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1352028

786 views
1 citation

Original Research

Published on 11 Mar 2024

Beneficial implications of adjuvant chemotherapy for stage IB lung adenocarcinoma exhibiting elevated SUVmax in FDG-PET/CT: a retrospective study from a single center

in Thoracic Oncology

Miao Huang
Bing Liu
Xiang Li
Nan Li
Xin Yang
Yaqi Wang
Shanyuan Zhang
Fangliang Lu
Shaolei Li
Shi Yan

Frontiers in Oncology

doi 10.3389/fonc.2024.1367200

925 views

Editorial

Published on 11 Mar 2024

Editorial: Pulmonary fibrosis and lung carcinogenesis: do myofibroblasts and cancer-associated fibroblasts share a common identity?

in Thoracic Oncology

Daniela de Totero
Emanuela Barisione
Enrico Clini

Frontiers in Oncology

doi 10.3389/fonc.2024.1389532

984 views

Systematic Review

Published on 08 Mar 2024

Application of three-dimensional technology in video-assisted thoracoscopic surgery sublobectomy

in Thoracic Oncology

Xinyu Zhang
Di Yang
Linqian Li
Jianing Wang
Si Liang
Peng Li
Zhe Han
Xiaodong Wang
Ke Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1280075

1,614 views

Original Research

Published on 08 Mar 2024

Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50%: real-world outcomes in a US community oncology setting

in Thoracic Oncology

Shirish M. Gadgeel
Pragya Rai
Srinivas Annavarapu
Sartaj Alam
Jerome H. Goldschmidt
Howard (Jack) West
Melissa Santorelli
Renata Eiras Martins

Frontiers in Oncology

doi 10.3389/fonc.2024.1298603

2,497 views

Review

Published on 07 Mar 2024

Ferroptosis in lung cancer: dual role, multi-level regulation, and new therapeutic strategies

in Thoracic Oncology

Yunbin Li
Xiaosong Li
Jian Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1360638

1,990 views
1 citation

Study Protocol

Published on 07 Mar 2024

Efficacy and safety of pembrolizumab as first-line treatment for advanced non-small cell lung cancer complicated with chronic obstructive pulmonary disease: protocol for a prospective, single-arm, single-center, phase II clinical trial

in Thoracic Oncology

Weigang Dong
Yan Yin
Bin Liu
Yan Jiang
Lei Wang
Dongsheng Shi
Jianwen Qin

Frontiers in Oncology

doi 10.3389/fonc.2024.1179232

1,677 views
1 citation

Original Research

Published on 05 Mar 2024

Lung adenocarcinoma: selection of surgical approaches in solid adenocarcinoma from the viewpoint of clinicopathologic features and tumor microenvironmental heterogeneity

in Thoracic Oncology

Xiao Li
Zhen Gao
Haixiao Diao
Chenran Guo
Yue Yu
Shang Liu
Zhen Feng
Zhongmin Peng

Frontiers in Oncology

doi 10.3389/fonc.2024.1326626

1,118 views
1 citation

Case Report

Published on 01 Mar 2024

Case report: Primary pulmonary low grade fibromyxoid sarcoma progressing to dedifferentiation: probably due to TP53 driver mutation

in Thoracic Oncology

Jiawen Zhang
Haisheng Fang
Xiaomei Zhu
Chenchen Yao
Qinhe Fan
Qixing Gong

Frontiers in Oncology

doi 10.3389/fonc.2024.1329264

1,307 views

Navigation group

Articles

Preoperative systemic immune-inflammation index-based nomogram for lung carcinoma following microwave ablation -a real world single center study

Radiomics model based on intratumoral and peritumoral features for predicting major pathological response in non-small cell lung cancer receiving neoadjuvant immunochemotherapy

Plasma metabolomics reveals risk factors for lung adenocarcinoma

Anti-angiogenic therapy or immunotherapy? A real-world study of patients with advanced non-small cell lung cancer with EGFR/HER2 exon 20 insertion mutations

Case report: Complex left-carina resection: three-year single-center experience

Case report: Bronchoscopic intervention for rare benign airway tumors: a report of 4 cases and literature review

The application of artificial intelligence for Rapid On-Site Evaluation during flexible bronchoscopy

Diagnosis of benign and malignant peripheral lung lesions based on a feature model constructed by the random forest algorithm for grayscale and contrast-enhanced ultrasound

Beneficial implications of adjuvant chemotherapy for stage IB lung adenocarcinoma exhibiting elevated SUVmax in FDG-PET/CT: a retrospective study from a single center

Editorial: Pulmonary fibrosis and lung carcinogenesis: do myofibroblasts and cancer-associated fibroblasts share a common identity?

Application of three-dimensional technology in video-assisted thoracoscopic surgery sublobectomy

Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50%: real-world outcomes in a US community oncology setting

Ferroptosis in lung cancer: dual role, multi-level regulation, and new therapeutic strategies

Efficacy and safety of pembrolizumab as first-line treatment for advanced non-small cell lung cancer complicated with chronic obstructive pulmonary disease: protocol for a prospective, single-arm, single-center, phase II clinical trial

Lung adenocarcinoma: selection of surgical approaches in solid adenocarcinoma from the viewpoint of clinicopathologic features and tumor microenvironmental heterogeneity

Case report: Primary pulmonary low grade fibromyxoid sarcoma progressing to dedifferentiation: probably due to TP53 driver mutation